The Sydney Myopia Study: Prevalence And Risk Factors For Myopia And Other Eye Conditions In School-age Children.
Funder
National Health and Medical Research Council
Funding Amount
$596,375.00
Summary
This study aims to establish the exact extent of increasing levels of myopia in young Australians and the frequency of other treatable eye conditions such as reduced vision in one eye (amblyopia) and squint. We also aim to exam in detail, risk factors associated with myopia, such as parental myopia, living conditions and educational pressures, particularly those associated with reading and other forms of near-work. Increased understanding of factors leading to increasing myopia prevalence may en ....This study aims to establish the exact extent of increasing levels of myopia in young Australians and the frequency of other treatable eye conditions such as reduced vision in one eye (amblyopia) and squint. We also aim to exam in detail, risk factors associated with myopia, such as parental myopia, living conditions and educational pressures, particularly those associated with reading and other forms of near-work. Increased understanding of factors leading to increasing myopia prevalence may enable design of preventive strategies that could limit future increases in the ocurrence of myopia in Australia. The prevalence of myopia is increasing world-wide. In many Asian countries, it has reached epidemic proportions (80-90%) in young, educated people. In many other countries close to half the younger population is now short-sighted. Data from the Blue Mountains Eye Study and Melbourne Visual Impairment Project in older persons have suggested that the prevalence of myopia is increasing in Australia. Comparison with our recent pilot study on school children indicates that myopia prevalence has increased 2 to 3-fold in recent decades. Myopia or short-sightedness is now one of the five major causes of blindness. In countries where the prevalence of myopia is high, it is one of the top three. Myopia requires expensive optical and-or surgical correction of the refractive error for visual functioning. Unfortunately correction does not prevent the development of visual impairment and blindness from complications of myopia. Late in life, even low myopia is associated with an increased risk of both glaucoma and cataract. Myopia therefore imposes additional major health costs because of the burden of eye disease and the support costs for people affected by myopia-associated low vision or blindness. With increasing prevalence, the health care costs of myopia are likely to continue to rise in Australia.Read moreRead less
Characterising The Changes In Regulation Of Visual Contrast Sensitivity In Glaucoma.
Funder
National Health and Medical Research Council
Funding Amount
$337,600.00
Summary
Glaucoma is the second leading cause of blindness in developed nations. A recent study estimated the number of Australian's that will need regular visual examination in 2030 either because they have glaucoma or glaucomatous risk factors to be at least 800,000. As the ultimate aim of glaucoma treatment is to maintain vision, visual functional assessment is of paramount importance to glaucoma management . The current standard measure for the assessment of visual loss due to glaucoma is visual fiel ....Glaucoma is the second leading cause of blindness in developed nations. A recent study estimated the number of Australian's that will need regular visual examination in 2030 either because they have glaucoma or glaucomatous risk factors to be at least 800,000. As the ultimate aim of glaucoma treatment is to maintain vision, visual functional assessment is of paramount importance to glaucoma management . The current standard measure for the assessment of visual loss due to glaucoma is visual field testing. Regrettably, substantial damage to retinal ganglion cells (the primary neurons affected by glaucoma) is often present prior to the discovery of visual field loss using standard measures. Indeed studies have demonstrated that even 30-50% retinal ganglion cell loss may only manifest as a mild visual field deficit using current standard testing. This project will use novel techniques for exploring sight impairment in glaucoma, enabling a better understanding of the underlying neural damage. Our pilot work demonstrates that these methods can detect loss of sight in areas diagnosed as normal using standard visual field testing. The study will provide new technologies for the assessment of early vision loss due to glaucoma that may enable the detection of malfunction of retinal ganglion cells prior to their death. Such measures of neural malfunction are essential to establishing the efficacy of new pharmacological therapies (known as neuroprotective agents) for glaucoma aimed at keeping retinal ganglion cells alive and functioning. This project also has the potential to identify visual measures that have better capability for monitoring the progression of vision loss due to glaucoma. Early detection of glaucoma and its progression is essential so that treatment can be initiated or altered, slowing the progression of vision loss and its toll on both the individual and the community.Read moreRead less
Genetic And Molecular Basis Of Congenital Cataracts
Funder
National Health and Medical Research Council
Funding Amount
$454,510.00
Summary
Cataracts are caused when the lens of the eye (which focuses light), loses transparency. They typically occur in older individuals, but can also occur in children, even as early as from birth. They usually result in severe vision impairment which can result in complete blindness. The only treatment is invasive surgery where the outcomes are poor, particulary in very young children. This research aims to discover the genes that cause cataract in children and to investigate how cataracts form. We ....Cataracts are caused when the lens of the eye (which focuses light), loses transparency. They typically occur in older individuals, but can also occur in children, even as early as from birth. They usually result in severe vision impairment which can result in complete blindness. The only treatment is invasive surgery where the outcomes are poor, particulary in very young children. This research aims to discover the genes that cause cataract in children and to investigate how cataracts form. We are working with several large Australian families that have severe childhood cataracts in order to identify the specific genes that cause their disease. This is achieved through an investigation of the entire genome of these families which allows us to precisely pinpoint any genetic changes. We can then look for these changes in the genes in other childhood cataract patients as well as in adults with cataracts. This information will increase our understanding of how the lens of the eye works and how cataracts can form. One gene that can cause cataracts has already been identified, this is the Nance-Horan Syndrome gene. We will investigate the role of this gene in the lens of the eye. This gene also causes other severe disabilities including mental retardation. The exact function of this gene is unknown but by determining how it works we will be able to better understand cataract formation and mental retardation, with the ultimate aim of developing better diagnosis and timely treatment for these disorders.Read moreRead less
Therapeutic Control Of Pathological Myopia: Role Of Transforming Growth Factor-beta
Funder
National Health and Medical Research Council
Funding Amount
$312,730.00
Summary
Myopia (shortsightedness) is due to the eye being too long. It is a common refractive disorder, affecting some 25-30% of people in developed countries, and results in blurred distance vision. The optical consequences of myopia, namely blurred distance vision, are correctable with spectacles or contact lenses. However, a significant minority of individuals (3% of the Australian population) have excessively long eyes and high amounts of myopia. These enlarged eyes impose abnormal stresses on the s ....Myopia (shortsightedness) is due to the eye being too long. It is a common refractive disorder, affecting some 25-30% of people in developed countries, and results in blurred distance vision. The optical consequences of myopia, namely blurred distance vision, are correctable with spectacles or contact lenses. However, a significant minority of individuals (3% of the Australian population) have excessively long eyes and high amounts of myopia. These enlarged eyes impose abnormal stresses on the structures inside, particularly affecting the retina, which is the light sensitive part of the eye. Damage that occurs to the retina in these eyes is, at present, untreatable and irreversible and can result in blindness. Myopia is the 2nd leading cause of blindness amongst adults of working age. For the eye to grow so large, its white outer coat (the sclera) must expand without allowing any leaks of the delicate structures and fluids inside. Although the sclera gets very thin as it expands, it has been shown that this process of expansion is a biochemically active process and not due to passive stretch. Before elongation of the eye can occur the biochemical structure of the sclera must change, a complex process involving accelerated production and breakdown of the biochemical building blocks of the sclera. Previous research in our laboratory indicates that changes in structure of the sclera are associated with reduced levels of the growth-controlling protein transforming growth factor-beta (TGF-beta). The aim of this project is to supplement TGF-beta levels in the sclera in order to reverse the loss of scleral tissue, stop the development of myopia and, therefore, prevent the development of the sight-threatening pathology associated with high myopia. In addition, we will determine the most effective way to deliver a sustained dose of TGF-beta to the sclera.Read moreRead less
Dissecting The Pseudoexfoliation Syndrome With Complementary Genetic, Proteomic And Biophysical Strategies
Funder
National Health and Medical Research Council
Funding Amount
$490,352.00
Summary
Pseudoexfoliation syndrome (PEX) is an eye condition in which flaky material deposits in the eye, greatly increasing the risk of cataract and glaucoma which can lead to blindness. PEX is also associated with heart disease, strokes and aneurysms. Cataract surgery in PEX patients has a higher rate of complications. In this project we will determine the nature of PEX material and why it forms. This knowlege will facilitate better diagnosis and treatment of PEX preventing associated blindness.
A Genome-wide Association Scan To Identify Genetic Risk Factors For Sight Threatening Diabetic Retinopathy
Funder
National Health and Medical Research Council
Funding Amount
$982,203.00
Summary
Diabetic eye disease is an important complication of diabetes that can lead to blindness. Very little is known about how diabetes causes eye disease, but genetics is known to play a role. We aim to identify genes that contribute to eye disease in diabetes patients. We will compare genes between patients with diabetes with and without severe diabetic eye disease using cutting edge genomic technology. We hope to be able to better predict risk of blindness and to move towards novel treatments.
Role Of Osteopontin In Ischemic-like Injury To The Retina
Funder
National Health and Medical Research Council
Funding Amount
$357,862.00
Summary
The molecule osteopontin (OPN) is implicated in the response of certain tissues to disease. We have new evidence that the level of OPN in the visual retina increases markedly following injury. We hypothesise that OPN is produced by specialised retinal cells in response to injury and functions to promote the survival of nerve cells. The proposed research seeks to investigate this hypothesis and the results will contribute to a greater understanding of the role of OPN in retinal diseases.
Understanding The Genetic Determinants Of Central Corneal Thickness And Its Functional Role In Glaucoma Pathophysiology
Funder
National Health and Medical Research Council
Funding Amount
$297,263.00
Summary
Glaucoma is a common cause of blindness and visual diability in Australia. It is caused by a combination of environmental and genetic factors. People with a thin cornea (the clear covering at the front of the eye) are at increased risk of glaucoma. We are investigating the biological link between the cornea and glaucoma as well as identifying genes that determine corneal thickness. Some of these genes may also cause glaucoma. Understanding this will lead to better diagnosis and treatment.
The Role Of Tau In Experimental Retinal And Optic Nerve Pathology: Relevance To Glaucoma
Funder
National Health and Medical Research Council
Funding Amount
$375,225.00
Summary
Aberrant processing of the axonal protein, tau, is believed to underlie key pathological events in Alzheimer's Disease (AD). Recent data have suggested a link between AD pathology and retinal neuron death in glaucoma. We have further evidence that changes in tau also occur in models of retinal damage. We thus aim to characterise the role of tau in retinal injury models and to relate these findings to glaucoma with a view to having a greater understanding of this disease process.
The Role Of Ten-m3 In Patterning Ipsilateral Retinal Projections
Funder
National Health and Medical Research Council
Funding Amount
$453,042.00
Summary
The normal functioning of the brain depends on connections of billions of nerve cells or neurons. We have found that a protein called Ten_m3 plays a very important role in specifying the way that neurons from the eye connect to the brain. The role of this protein is so important that mice which lack the protein behave as if they are blind. The aim of this project is to understand how this protein controls the development of the visual system.